In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 61 for your search:
Drug:  arsenic trioxide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: LAP-R2007, NCT00504764

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Enrolling by invitation
Age: 18 to 75
Sponsor: Other
Protocol IDs: GDREC2013109H(R1), NCT01861912

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-2012-02811, C9710, CDR0000067126, CALGB-C9710, U10CA031946, CAN-NCIC-AL3, COG-C9710, ECOG-C9710, SWOG-C9710, CAN-NCIC-C9710, AL3, NCT00003934

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: APL0406, GIMEMA-SAL-APL0406, EUDRACT-2006-006188-22, GIMEMA-DSL-APL0406, EU-20725, NCT00482833

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000553210, S0521, U10CA032102, SWOG-S0521, NCT00492856

7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 2 to 21
Sponsor: NCI
Protocol IDs: COG-AAML0631, COG-AAML0631, AAML0631, NCT00866918

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000066617, WU-98-0185, NCI-V98-1466, NCT00008697

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: SCCC-20010, SCCC-NCI-43, NCI-43, NCT00006021, 43

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-03126, NCT00081133

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0603-887, NCT00195104

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: 2005-0893, NCT00469209

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1888.00, FHCRC-1888.00, CDR0000380742, NCT00093366

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 04C1, CDR0000456504, STU00007792, NCT00275067

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000269319, OHSU-UCLA-0206062, OHSU-HEM-02001-L, OHSU-1096, NCT00053248

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: No age specified
Sponsor: NCI
Protocol IDs: PLRX-AS01, MSKCC-98025, NCI-H98-0012

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: OLMMC-9808, OLMMC-FDR001699, NCI-V99-1545, NCT00003885

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000067382, AECM-1199908270, NCI-T99-0077, AECM-CCRC-9929, T99-0077, NCT00004149

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: MSKCC-99051, NCI-T99-0062, NCT00005040, T99-0062

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: MSKCC-99107, NCI-T99-0105, NCT00005069, T99-0105

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: MSKCC-99076A, NCI-190, NCT00005618, 190

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: MSKCC-00018, NCI-30, NCT00005999, 30

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-9998, NCT00006008, E9998

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02789, CALGB-99903, U10CA031946, CLB-99903, NCT00009867

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 00-072, MSKCC-00072, NCI-H01-0073, NCT00016159
1    
New Search